One of the most recent studies out of Greece involved researchers looking into a vaporized weed formula with 13% CBD and 9% THC, and its effects on 69 patients with multiple sclerosis. The participants had varying symptoms, including muscle spasticity, bladder dysfunction, and disability progressions, all of which were analyzed at baseline levels to be evaluated again at three then six months. According to the researchers, “Significant improvement was observed across all outcome assessments,” after the patients were given vaporized weed.
Germany has received nearly 900 applications for cannabis cultivation associations, but only just over half…
A Senate stopgap funding bill would delay the federal prohibition on most hemp-derived THC products…
He smokes in boardrooms, but he’s still on that underground frequency. This content originally appeared…
Fox News opinion ran a piece recently from Scott Chipman, vice president of Americans Against…
For our 50th anniversary, we handed the plant to the artists making its most striking…
Corporate valuation increased in 21 of the 38 states studied following medical marijuana legalization. Gross…